Carregant...

Cutaneous Lupus Erythematosus: Updates on Pathogenesis and Associations with Systemic Lupus

PURPOSE OF REVIEW: Cutaneous lupus erythematosus (CLE) is a common manifestation among systemic lupus patients. There are no FDA approved therapies for CLE, and these lesions are frequently disfiguring and refractory to treatment. This will review will cover the recent inroads made into understandin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Curr Opin Rheumatol
Autors principals: Stannard, Jasmine N., Kahlenberg, J. Michelle
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4965280/
https://ncbi.nlm.nih.gov/pubmed/27270345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/BOR.0000000000000308
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!